Fugen Li

Also affiliated with Jiangsu T-mab BioPharma (China), First Affiliated Hospital of Nanchang University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer”.

Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer

UNC Libraries(2020)10.17615/c0ws-ey78

N/A

0DataRank · unranked

7 citations

Julián Carretero, Roderick T. Bronson, James E. Bradner, Charles Y. Lin, Myles Brown +26 more